Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Red Sox Rumors

Each MLB Team’s Players On WBC Rosters

By | at

The World Baseball Classic is returning this year, the first time since 2017. The quadrennial event was supposed to take place in 2021 but was scuttled by the pandemic, now returning after a six-year absence. Rosters for the tournament were announced today and those can be found at this link. Here is a breakdown of which players from each MLB team are set to take participate. Quick caveat that this list is fluid and might be changed as more information becomes available.

Without further ado…

Angels

Astros

Athletics

Blue Jays

Braves

Brewers

Cardinals

Cubs

Diamondbacks

Dodgers

Giants

Guardians

Marlins

Mariners

Mets

Nationals

Orioles

Padres

Phillies

Pirates

Rangers

Rays

Red Sox

Reds

Rockies

Royals

Tigers

Twins

White Sox

Yankees

The Volatile Red Sox Rotation

By | at

The Red Sox have been one of the more capricious teams in recent history. This millenium has seen them win the World Series four times but also finish fifth in the American League East five times. The past five seasons have seen them go from winning it all in 2018 to missing the playoffs in 2019, falling to last in 2020, back to the playoffs in 2021 but then back to the basement last year.

That mercurial nature seems to be embodied in this year’s rotation. There’s plenty of talent but also plenty of risk. It wouldn’t be a total shock to see this group be completely dominant or an utter disaster. Let’s take a look at the candidates and their respective error bars.

Chris Sale

From 2012 to 2018, Sale was one of the best pitchers in the league. He tossed 1,388 innings over that stretch with a 2.91 ERA, 30.2% strikeout rate, 5.4% walk rate and 42.7% ground ball rate. His 39.2 fWAR in that period was bested only by Clayton Kershaw and Max Scherzer.

Unfortunately, that’s starting to feel like ancient history now. Sale struggled in 2019 with a 4.40 ERA over 25 starts. That was the “juiced ball” season and his 19.5% HR/FB rate was a career high, so perhaps it wasn’t as bad as it seemed, but ERA estimators still pointed to him taking a step back from his previous work. The three subsequent seasons have been mostly lost to injuries, with Sale undergoing Tommy John surgery in March of 2020. He returned in 2021 and made nine starts that year, but then the injury bug came back the next season. A right rib stress fracture put him on the injured list to start the year, and then he was hit by a comebacker when he returned and suffered a left fifth finger fracture. While on the IL with that finger injury, he fractured his right wrist in a bicycle accident.

Some of those injuries are of the fluky variety and don’t necessarily point to any irreversible core issue. However, Sale will turn 34 years old in March and has pitched less than 50 major league innings in the past three years, including just 5 2/3 last year. It’s difficult to know what to expect from him after so little recent work, and even if he’s in good form, will he eventually hit some kind of wall? Either mandated by the club or just a physical limit?

James Paxton

Paxton is in a fairly similar situation to Sale, though his previous highs aren’t quite as high. From 2016 to 2019, he posted a 3.60 ERA over 568 innings. He struck out 28.5% of batters he faced while walking just 6.7% and got grounders at a 42.6% clip. His 15.1 fWAR in that period was 12th among all pitchers in the league. But various arm injuries have limited him to just six starts since then, with his last in April of 2021. He required Tommy John at that time and was on his way back last year but suffered a lat tear during his rehab.

The Sox could have locked him in for another two seasons by triggering a $26MM option but made the obvious choice to turn that down. Paxton then turned down a chance to return to free agency by triggering his $4MM player option for this year. Like Sale, he’s coming off three mostly lost seasons and will be 34 this year, but he’ll be almost two years removed from his last major league appearance once the season begins. Will he be able to get things back on track and, if so, for how long?

Corey Kluber

Kluber’s arc has some echoes of the two guys already mentioned in this piece, though with more optimistic developments recently. From 2014 to 2018, he made 160 starts with a 2.85 ERA, 28.5% strikeout rate, 5.2% walk rate and 44.8% ground ball rate. His 30.3 fWAR just nudged out Sale and trailed only Scherzer and Kershaw.

But after that, a forearm fracture and teres major muscle tear limited him to just eight starts over 2019 and 2020. He got back on track somewhat in 2021, as a shoulder strain sent him to the IL for about three months, but he still made 16 starts with a 3.83 ERA. He stayed healthy enough to take the ball 31 times last year, posting a 4.34 ERA. That came with excellent control as he walked just 3% of batters, but his strikeouts were down to a 20.2% clip.

Those past couple of seasons are encouraging but Kluber turns 37 in April. His fastball averaged 88.9 mph last year, well down from his 94-95 mph peak form. He seems like he has the ability to succeed despite that diminished stuff, but that will likely become more challenging over time, even if he does stay healthy.

Nick Pivetta

Compared to the three previous pitchers on this list, Pivetta is the picture of reliability. He hasn’t been to the injured list for a non-COVID reason during his time in the majors, which began in 2017.

However, that might be his best asset, as he hasn’t exactly wowed with the results. He has a 5.02 ERA for his career and registered a 4.56 mark last year. His 22.6% strikeout rate was slightly better than that of the average starter last year, but his 9.4% walk rate and 38.5% ground ball rate were both a few points worse. He’s not terribly exciting but there’s certainly value to that kind of steadiness, especially amid this erratic group.

Garrett Whitlock

Whitlock had a great season in 2021 after being plucked from the Yankees in the Rule 5 draft. He tossed 73 1/3 innings over 46 relief appearances with a 1.96 ERA, 27.2% strikeout rate, 5.7% walk rate and 49.7% ground ball rate. He began 2022 back in the bullpen but the Sox tried stretching him out midseason. He made nine starts before a hip issue sent him to the injured list in June. He returned in July but was kept in a relief role until the hip issue put him on the IL again in September. He underwent surgery for that hip at that time but is expected to be ready for spring.

The club plans on implementing him as a starter here in 2023, which will be an interesting experiment. The 120 2/3 innings he threw in the minors in 2018 are the most in a single season on his résumé, as he’s been in the 70-80 range since then. With just those nine big league starts to his name, can he suddenly jump to a full starter’s workload? And even if he can, will he be able to maintain the same quality of of work that he did in relief in 2021-22?

Tanner Houck

Houck is in a fairly similar boat to Whitlock, as there are intriguing results there but it’s tough to map out the best path forward. He has a 3.02 ERA in 146 innings for his career thus far, striking out 27.6% of batters faced, walking 8.7% and getting grounders at a 49.3% rate. That work has involved 20 starts and 33 relief appearances. The splits aren’t huge, as he has a 3.22 ERA as a starter and a 2.68 out of the ’pen. He dealt with lingering back issues last year that sent him to the injured list in August and he ultimately underwent surgery in September.

The club has indicated they may stretch Houck out as a starter in camp but move him to the bullpen if the five guys ahead of him are all healthy. That still leaves a decent chance of him spending some time in the rotation this year. He made just four starts last year and hasn’t reached 120 innings in any of his professional seasons.

Brayan Bello/Kutter Crawford/Josh Winckowski

These three all have made their major league debuts but likely need more time to develop. Bello registered a 4.71 ERA last year, with Crawford at 5.47 and Winckowski at 5.89. They all have options and might be in the minors to start the year. But given the unstable nature of the arms ahead of them on the depth chart, there’s a chance they will be needed at some point.

Brandon Walter/Bryan Mata/Chris Murphy

These three are all on the 40-man but have yet to reach the majors. Walter and Murphy just got added in November to protect them from the Rule 5 draft. Walter has just nine Double-A starts and two at Triple-A, meaning he likely won’t be lined up for his debut in the immediate future. Murphy made 15 Triple-A starts last year but put up a 5.50 ERA in that time. Mata underwent Tommy John in April of 2021 and was able to return last year and toss 83 innings in the minors, but he has just five Triple-A starts to his name thus far. This group could be called upon if things really go south, but they will likely be behind the Bello/Crawford/Winckowski trio unless things shift as the season progresses.

_____

As mentioned off the top, there’s plenty of talent here but there are so many ways this could play out. Five years ago, Sale, Paxton and Kluber would have been a dominant front three but the odds of them all suddenly clicking into their previous ace levels are low. Whitlock and Houck have had tantalizing results but each is coming off a season ended by surgery and both are generally unproven as starters over any kind of meaningful stretch. The younger depth options could always take a step forward and seize a job but they probably can’t be counted on yet.

It seems the error bars are quite wide for the Sox going into 2023. Center field and shortstop will be manned by players with minimal experience at those positions in Adam Duvall and Enrique Hernández, respectively. Their first baseman will be Triston Casas, who has 27 MLB games to his name. Their left fielder will be Masataka Yoshida, attempting to make the transition from NPB to MLB. They’re hoping to get some kind of contribution from Adalberto Mondesi, who’s been limited to just 50 games over the past two years combined. There’s uncertainty all over the place, including the rotation. In a style that fits the organization, they could have a miracle season or it could all go horribly wrong.

Players That Could Move To The 60-Day IL Once Spring Training Begins

By | at

Just about every baseball team has a full 40-man roster now, with the Astros the only team with an open spot at the moment. That means that just about every transaction, be it a free agent signing or a waiver claim, requires a corresponding move.

However, that could soon change as the injured list is coming back soon. There’s no IL from the end of a season until pitchers and catchers report to Spring Training for the next campaign, which they will do next week. That means some clubs could potentially gain a bit of extra roster flexibility at that time, since players on the 60-day IL don’t count against a team’s roster total. However, it’s worth pointing out that the “60 days” don’t start until Opening Day, which is March 30 this year. That means, though a team can transfer a player to the 60-day IL next week, they will likely only do so if they aren’t expecting the player back until end of May or later.

With some notable free agents still unsigned like Jurickson Profar, Andrew Chafin, Michael Wacha, Elvis Andrus and many others, it’s possible that teams interested in their services might try to hold off on getting a deal done until next week. Or perhaps clubs that have players they would like to sneak through waivers will try to do so now, before rival clubs gain that extra roster flexibility with the IL opening up. Then again, some clubs will need to keep in mind non-roster players they are planning to promote by Opening Day and might hold off on making a move until that time.

Here are some players who are expected to miss some significant time and could find themselves transferred soon, sorted by division.

AL East

Hyun Jin Ryu/Chad Green

The Blue Jays have a pair of pitchers on their 40-man roster who are returning from Tommy John surgery. They should be on a similar timeline, as they each underwent the procedure in June of last year, though Green will most likely return first since relievers generally require less time to build up arm strength compared to starters. Regardless, the recovery time period for TJS is about 12-18 months, meaning neither pitcher is likely to return until midseason at the earliest. Ryu recently said he was targeting a July return.

Trevor Story

The Red Sox shortstop recently underwent an internal brace procedure on his throwing elbow, a similar operation to Tommy John. Though he’s confident he’ll return at some point, he’s slated to miss most of the upcoming season and is certainly headed for the injured list.

John Means

The Orioles lefty underwent Tommy John surgery in late of April of 2022. With the 12-18 month recovery window for TJS, he could theoretically return in the first couple of months of the season, so the O’s may not want to transfer him to the injured list until they have some clarity about his timeline.

Scott Effross/Luis Gil/Frankie Montas

Effross is a lock for the Yankees’ injured list as he underwent Tommy John in October and will likely miss the entire 2023 campaign. Gil had the same surgery but in May, which means he’ll likely be out until midseason. The situation with Montas is a bit less clear, as he’s dealing with shoulder inflammation that is expected to keep him out for the first month of the season. Unless he suffers some sort of setback, he probably won’t be placed on the 60-day IL right away.

Shane Baz/Andrew Kittredge

The Rays have a couple of hurlers bound for the IL as Baz underwent Tommy John in September while Kittredge had the same surgery in June. They’re both going to miss the first half of the year, with Baz potentially missing the entire season.

AL Central

Casey Mize/Tarik Skubal

Mize underwent Tommy John surgery in June and should be placed on the Tigers’ IL at some point. Skubal’s case is a bit less certain after he underwent flexor tendon surgery in August. The club hasn’t provided a timeline for his recovery but some recent comparables can give us some idea. Danny Duffy underwent the procedure in October of 2021 and was hoping to return by June of 2022, though a setback prevented him from pitching at all on the year. Matthew Boyd went under the knife for flexor tendon surgery in September of 2021 and didn’t return to a big league mound until September of 2022.

Garrett Crochet/Liam Hendriks

Crochet of the White Sox underwent Tommy John surgery in April of last year but was already stretched out to throwing from 120 feet in November. Whether he’s able to return in the early parts of 2023 or not will depend on his continued progression in that recovery process. In a less conventional situation, Liam Hendriks announced last month that he’s beginning treatment for non-Hodgkin’s lymphoma. It’s unknown how long his treatment will take but general manager Rick Hahn said they don’t expect updates “prior to Opening Day at the very earliest.”

Chris Paddack/Royce Lewis

Paddack was recently extended by the Twins though he underwent Tommy John in May of last year and likely won’t be ready to return until the middle of the upcoming campaign. Lewis tore the anterior cruciate ligament in his right knee in June of last year, the second year in a row that he suffered that unfortunate injury. At the time, his recovery timeline was estimated at 12 months, which likely puts him on the shelf until midseason as well.

AL West

Brett Martin

It was reported last month that the Rangers lefty will require shoulder surgery. It was said that the timeline will become more clear in the aftermath of the procedure but he’s likely to miss the entirety of the upcoming season.

NL East

Bryce Harper

The Phillies superstar underwent Tommy John surgery in November and the club has announced they expect him to be out of action until around the All-Star break in July.

Huascar Ynoa/Tyler Matzek

Both these Braves pitchers underwent Tommy John last year, with Ynoa going under the knife in September and Matzek in October. That makes them both long shots for appearing at all this year, but especially not in the first half.

Max Meyer/Anthony Bender/Sixto Sanchez

The Marlins have a couple of arms that will certainly miss time this year and one more that’s a wild card. Meyer and Bender both underwent Tommy John in August and will miss most of the upcoming campaign. Sanchez underwent arthroscopic shoulder surgery in October with the club announcing at that time they expected him back by spring. It was reported last month that Sanchez is already throwing bullpens, which perhaps points against an IL stint. However, after the shoulder issues completely wiped out his 2021 and 2022 seasons, it’s hard to know how much to rely on his health going forward.

Danny Mendick

The Mets signed Mendick after he was non-tendered by the White Sox. The infielder/outfielder tore the anterior cruciate ligament in his right knee in June of last year and missed the second half of the season. There haven’t been any updates on his status recently, but further clarity will likely come when camp gets rolling.

Tanner Rainey/Stephen Strasburg

The Nationals have one fairly straightforward case in Tanner Rainey, who underwent Tommy John in August and will likely miss most of the upcoming season. What’s less clear is the situation surrounding Strasburg, who’s hardly pitched at all over the past three years due to thoracic outlet syndrome and various issues seemingly related to that. He made one appearance in the big leagues last year, pitching 4 2/3 in one start in June but went on the IL right after and never returned. He spoke about the issue in September, saying he hadn’t thrown in months and that he is “not really sure what the future holds.”

NL Central

Ethan Roberts/Codi Heuer/Kyle Hendricks

Roberts underwent Tommy John in June and likely won’t be available for the Cubs until midseason. Heuer had TJS in March but the latest reporting suggests he won’t return until June or July. The status of Hendricks is less clear, with the righty trying to recover from a capsular tear in his shoulder. The club is hoping to have him back by Opening Day but also said they won’t rush him. He recently said that he’s expecting to be on a mound by March 1.

Vladimir Gutierrez/Tejay Antone

Gutierrez, a Reds righty, underwent Tommy John in July and should miss the first few months of the upcoming season at least. Antone was rehabbing from a Tommy John of his own when he suffered a flexor strain in his forearm. He announced today he’s received a platelet-rich plasma injection to treat the issue and suggested he might miss the first half of the season.

Max Kranick

The Pirates right-hander required Tommy John in June and will miss the first half of the upcoming campaign.

NL West

Antonio Senzatela/Tyler Kinley

The Rockies have a couple of murky situations on their hands with these hurlers. Senzatela tore the anterior cruciate ligament in his left knee last year and required surgery in August. The timeline at that point was given at 6-8 months, which would place his return somewhere in the February-April window. Whether he’ll require a lengthy IL stint will depend on if his recovery is still on that track. Kinley was diagnosed with an elbow strain and a flexor tear in his forearm in June of last year. He underwent surgery in July with the club announcing they expected him to miss one calendar year, which should prevent him from pitching early in the campaign.

Walker Buehler/Blake Treinen/J.P. Feyereisen

The Dodgers have a trio of pitchers that are likely to miss most or perhaps all of the upcoming season. Buehler required Tommy John in August and could potentially return very late in the year. Treinen underwent shoulder surgery in November with an estimated recovery time of 10 months. Feyereisen underwent shoulder surgery in December and won’t be able to begin throwing until four months after that procedure, or around April. His eventual return to game shape will depend on how long it takes him to progress from simply throwing to getting up to full game speed.

Luke Jackson

The Giants signed the right-hander in free agency, despite Jackson undergoing Tommy John in April. President of baseball operations Farhan Zaidi told reporters last month that there was a chance Jackson begins the year on the 60-day IL, though that doesn’t seem to indicate any kind of setback. “He’s doing great in his rehab, so we’re going to wait and see how he’s doing in spring training,” Zaidi said.

AL Notes: Ohtani, Angels, Vespi, Yoshida, Red Sox

By | at

Despite the busy Angels offseason, Shohei Ohtani’s future remains the team’s biggest question in 2023, and Arte Moreno’s decision not to sell the Angels adds another layer of intrigue to Ohtani’s situation.  Speaking with reporters (including the Associated Press), Halos GM Perry Minasian reiterated that the organization would love to keep Ohtani, and suggested that Moreno was willing to pay Ohtani the record-setting contract it might take to keep the two-way star in Anaheim.  “[Moreno has] already invested in this club throughout his whole ownership.  We’ve been top-10 in payroll for a long time,” Minasian said.  “I don’t see that changing.  Knowing [Moreno] and knowing how much he wants to win, I wouldn’t put anything out of the realm of possibility.”

Desire to win notwithstanding, Moreno’s ability to construct a winning team is the another factor, as the Angels are mired in a string of seven consecutive losing seasons.  Unsurprisingly, Ohtani was openly disappointed by the Halos’ lackluster 2022 campaign, and any doubts he has about the Angels’ ability to compete might possibly result in Ohtani signing with a more proven contender next winter.  Even if Moreno is willing to splurge on Ohtani and take the Angels into luxury tax territory, it might not be enough to sway Ohtani from a comparable offer from a winning team.

More from around the American League….

  • Orioles left-hander Nick Vespi underwent hernia surgery in early January, and the reliever told MASNsports.com’s Roch Kubatko that he is “cleared to throw, so I am starting to throw already and I’ll be ready for Opening Day.”  There was some doubt as to whether or not Vespi’s recovery process might last into the early part of the season, and while it appears that might not be an issue, Vespi will miss pitching for Italy in the World Baseball Classic.  Vespi made his MLB debut in 2022, posting a 4.10 ERA over 26 1/3 innings out of the Orioles’ bullpen.  Cionel Perez and Keegan Akin are Baltimore’s top southpaw options in the relief corps, though Vespi may face further competition from any left-handed starting candidates who don’t make the rotation.
  • The Red Sox signed Masataka Yoshida to a five-year, $90MM deal in December, an investment that surpassed all projections for Yoshida as he made the move from Nippon Professional Baseball to the majors.  That said, the Sox also feel “other teams were prepared to bid more aggressively for Yoshida than has been widely reported,” the Boston Globe’s Alex Speier writes.  The Blue Jays and Dodgers were reportedly the other finalists for Yoshida’s services, though it isn’t known what those two clubs were willing to pay.  The $90MM guarantee is also a sign of just how much faith the Red Sox have in Yoshida’s ability to continue his production against Major League pitching, which is a belief born from heavy scouting and evaluation of Yoshida in Japan over the last three years.

Red Sox Sign Jake Faria To Minor League Contract

By | at

The Red Sox have signed right-hander Jake Faria to a minor league deal, according to MassLive.com’s Chris Cotillo (Twitter links).  The contract includes an invitation to Boston’s big league Spring Training camp, and a guaranteed $735K salary if Faria makes the active roster.

Since the start of the 2019 season, Faria has pitched only 51 1/3 MLB innings — 32 2/3 frames with the Diamondbacks in 2021, and 18 2/3 innings split between the Rays and Brewers in 2019.  In between those stints in the majors, Faria also pitched at the Triple-A level with the Angels in 2021 and with the Twins last season, with a cumulative 6.64 ERA over 80 innings over the last two years.

It has been a tough ride for Faria in recent years, after he came up through Tampa Bay’s farm system with a lot of promise, and had a quick start to his MLB career with a solid 3.43 ERA over 86 2/3 innings in his 2017 rookie season.  Red Sox chief baseball officer Chaim Bloom was working in the Rays’ front office during Faria’s tenure in Tampa, so the minor league deal will give Bloom a chance to see first-hand if Faria can recapture any of that old form.

Not counting those 2017 numbers, Faria otherwise has a 5.65 ERA and underwhelming strikeout and walk rates over 116 1/3 innings as a Major League pitcher.  Home runs have been an issue, as Faria has allowed 19 homers in that limited 116 1/3 inning sample size.  While Faria has still regularly worked as a starter at Triple-A, he has mostly been utilized as a reliever in the majors since 2018, so the Red Sox likely view him as a multi-inning reliever at best if he can win a job in their bullpen.

AL East Notes: Orioles, DL Hall, Red Sox

By | at

The Orioles took a major step forward last season, and now general manager Mike Elias has declared their rebuild over.

“I believe that our rebuild is behind us. We’ve got an incredible chance now to be a very, very competitive team for years,” Elias told reporters, including Rich Dubroff of BaltimoreBaseball.com.

That team will depend on the performance of it’s young core, led by Adley Rutschman, Gunnar Henderson and soon to include Grayson Rodriguez. Yet while the team is stocked with exciting young talent Orioles fans may have some reason to feel a little disappointed by the team’s modest acquisitions in the off-season thus far.

They’ve so far brought in starters Kyle Gibson and Cole Irvin, added reliever Mychal Givens, infielder Adam Frazier and catcher James McCann. While that group can all help the Orioles it’s not the splashy addition some might have been hoping for as the O’s look to compete in the tough AL East, yet Elias isn’t ruling out further additions by trade or in free agency.

“There are quality free agents remaining. We’re staying in touch in them. We’re still pursuing opportunities. There are some players on the free-agent market that interest us,” Elias said.

Given the dwindling options in free agency, it’s likely any signing would be more of a depth piece rather than an impact player. Baltimore was connected to free agent starter Michael Wacha throughout the off-season, but the addition of Irvin would seemingly make any more rotation additions unlikely. They’ve also been reported to be in the market for a defensive-minded outfielder.

Here’s a couple more notes from the AL East:

  • Sticking with the Orioles to begin with, Elias says there are 12 players in the mix for the starting rotation come Opening Day. Gibson and Irvin are locks, while Elias has already said he expects top pitching prospect Grayson Rodriguez to make the team’s rotation out of camp, so that’d leave nine players competing for the final two spots. One of them will be prospect DL Hall, with Elias saying he’ll have a chance to compete for a rotation spot in the spring. Hall came in at 84th on Keith Law’s recently published top-100 prospect list. He did get a brief cup of coffee in the big leagues last year, but it’s possible the Orioles look to keep him at Triple-A at least to begin the season.
    MLBTR’s Steve Adams took a deeper look at Baltimore’s rotation options recently, but other candidates include Kyle Bradish, Dean Kremer, Tyler Wells, Austin Voth and Spenser Watkins.
  • The Red Sox won’t be aggressive in seeking further upgrades to their roster, but they are at least keeping the door open to making a move, particularly in the middle-infield, per Alex Speier of the Boston Globe. Chief baseball officer Chaim Bloom said the team likes the group they’ve got, so it seems likely that further moves would be minor league deals or bench pieces. Enrique Hernandez and Adalberto Mondesi are slated to handle the bulk of the middle-infield reps in 2023, with Christian Arroyo the top option off the bench.

White Sox Acquire Franklin German, Designate Jason Bilous

By | at

The White Sox have acquired right-hander Franklin German from the Red Sox in exchange for righty Theo Denlinger.  Both teams have announced the trade, and the White Sox also announced that right-hander Jason Bilous was designated for assignment to create roster space.

Boston designated German for assignment earlier this week, in a bit of a surprising move given that the Red Sox had named German their minor league pitcher of the year.  German had a 2.72 ERA and a very impressive 32.49% strikeout rate over 49 2/3 total innings between Boston’s Double-A and Triple-A affiliates, all in bullpen work.  This performance earned German his first bit of Major League action, though he had an 18.00 ERA over his four innings in the Show.

2022 was German’s first season as a full-time reliever, as he started to run into some struggles working his way up the ladder as a minor league starter.  It could be that the move to the bullpen might be a turning point for the 25-year-old German, and the White Sox seem interested in seeing if his 97mph fastball can translate to consistent results as a relief pitcher.

On the flip side, the Red Sox are also picking up a live arm in Denlinger, who has a 35.02% strikeout rate over 65 innings in the minors.  Denlinger only began his pro career in 2021 when Chicago drafted him in the seventh round, but the 26-year-old already advanced to Double-A last season, albeit with a 4.70 ERA over 38 1/3 frames with Double-A Birmingham.  Home runs contributed to that total, so if Denlinger can improve on keeping the ball in the park, a Triple-A promotion and maybe even a cup of coffee in the majors isn’t inconceivable for 2023.

Bilous, 25, was added to Chicago’s 40-man roster last offseason in advance of the Rule 5 Draft, though he was coming off a shaky season at the high-A and Double-A levels.  Unfortunately for Bilous, those struggles continued into 2022, as he posted a 6.30 ERA over 105 2/3 combined innings (83 2/3 at Double-A, 22 at Triple-A).  While his strikeout rates were still respectable, Bilous’ walk rate spiked to 15.74%.  It is possible that a bullpen move could conceivably be in Bilous’ future as well, though his four-pitch arsenal might lead the White Sox or another club to continue to explore a future as a starter.

Red Sox Notes: Barnes, Bleier, Paxton, Bello, Pivetta

By | at

The Red Sox made a change to their bullpen earlier this week, shipping out Matt Barnes to the Marlins for Richard Bleier. Boston reportedly paid down around $5.5MM to facilitate that deal, a testament to Barnes’ struggles since he signed a two-year, $18.75MM extension in July 2021.

That trade came a few days after the Sox had designated Barnes for assignment, a move that registered as a surprise even given the righty’s uneven past year and a half. The UCONN product had spent his entire career with the Red Sox since being drafted in the first round in 2011, and he indicated he was taken aback by the DFA.

“It was a complete blindside,” Barnes told reporters (including Chris Cotillo of MassLive) about being taken off the 40-man roster. While he indicated he doesn’t have any animosity about his time in Boston, Barnes also intimated he wasn’t enamored with his usage last season. By the second week of May, he was deployed mostly in low-leverage situations. Between May 6 and 30, he was called upon ten times. Seven of those contests saw the Sox either trailing late or leading a blowout contest, with Barnes relegated to mop-up work.

“We got to a point in the season where we were either blowing people out or losing a game and unfortunately for me, those are the games I was throwing at that point,” he said. “My workload in the games increased along with the amount of work I was doing to get back to what was normal for me. That’s when my shoulder flared up.” Barnes hit the injured list retroactive to May 31 with shoulder inflammation, an injury that kept him out of action until early August.

Of course, the lack of high-leverage work was in response to Barnes’ struggles. He’d been tagged for an 8.65 ERA in 10 appearances through May 5. That was on the heels of a 6.48 showing in the second half of 2021 that led the Sox to leave him off the playoff roster. He actually fared quite well to close out the 2022 campaign, posting a 1.66 ERA in 23 games to finish out the year. That wasn’t enough to grab a lasting 40-man spot over the winter, perhaps due to a still diminished 21.7% strikeout rate in that stretch.

Red Sox’s chief baseball officer Chaim Bloom discussed the Barnes DFA and subsequent trade on the Fenway Rundown podcast with Cotillo yesterday. Bloom noted that trading Barnes to Miami was “not something that we knew was going to happen at the time of the DFA,” suggesting the opportunity to make the trade arose after the reliever lost his roster spot. He pointed to Bleier’s propensity for weak contact and previous success in the AL East as a member of the Yankees and Orioles as reasons he was an appealing target for the front office.

Bleier adds a second left-hander to the Boston relief corps, joining offseason signee Joely Rodríguez. The Sox had a decent amount of turnover in that regard, waiving Darwinzon Hernández, trading Josh Taylor for Adalberto Mondesi, and seeing Matt Strahm depart via free agency. Boston has starting pitching prospects like Chris Murphy and Brandon Walter who could theoretically factor into that mix after securing 40-man roster spots.

James Paxton is another southpaw on the roster. He’s pitched just six MLB games over the past three seasons due to arm injuries. That’s raised some speculation about the possibility of the veteran seeing action in relief as a means of building his innings gradually. Bloom didn’t rule that out entirely, though he cautioned that might not be prudent for a pitcher who has started all 137 of his career big league outings.

“At the stage of his career that he’s at and having been through as much medically as he’s been through, adding the variable of asking him to do something he hasn’t really done is something we would have to think long and hard before doing,” Bloom told Cotillo. “That doesn’t rule it out, but you do have to factor that in.”

The Boston baseball operations leader also pushed back against the possibility of using young righty Brayan Bello out of the bullpen, pointing to his “ceiling of being a really good starting pitcher.” Bloom did note that Boston could “creatively” manage workloads early in the season but made clear the team still views Bello’s future as a starter. Jen McCaffrey of the Athletic writes there’s similarly no consideration of moving Nick Pivetta to the bullpen. Between that trio, Chris Sale, offseason signee Corey Kluber and the rotation conversion for Garrett Whitlock, it seems things are trending towards Tanner Houck sticking in relief for the upcoming season.

Red Sox, Marlins Swap Matt Barnes For Richard Bleier

By and | at

The Red Sox and Marlins swapped relievers Monday afternoon, with righty Matt Barnes dealt to Miami for southpaw Richard Bleier. Boston is also reportedly sending a little more than $5.5MM in cash in the deal to make the transaction nearly cash-neutral.

Barnes, 32, was designated for assignment by the Red Sox last week following the completion of a one-year, $7MM agreement with outfielder Adam Duvall. He served as Boston’s primary closer in 2021, earning a team-leading 24 saves. The 2021 campaign, however, was something of a tale of two seasons for Barnes. He dominated to the tune of a 2.25 ERA and a 42% strikeout rate through Aug. 4. Barnes was impressive enough that the Sox inked him to a two-year, $18.75MM extension in early July.

Over the final two months of the 2022 season, however, Barnes not only struggled but melted down in catastrophic fashion. He pitched just 10 2/3 innings from Aug. 5 onward, yielding a dozen runs on 17 hits and nine walks with 16 strikeouts along the way. It was a calamitous end to a what had begun as one of the best seasons among all Major League relievers.

Barnes hoped to right the ship in 2022 but promptly lost the closer’s job early in the year when he stumbled to a 7.94 ERA through the end of May.  The right-hander was always going to be much lower among the team’s high-leverage considerations in 2023, following the December additions of Kenley Jansen and Chris Martin — a pair of moves that was in large part necessitated by Barnes’ struggles.

Nonetheless, it’s worth pointing out that Barnes finished on a high note that likely intrigued Miami and other clubs. He was on the injured list from early June through early August due to shoulder inflammation, and upon returning, he looked much more like the Barnes of old. Beginning on Aug. 4 — the same point at which he began to struggle a year prior — Barnes pitched 22 2/3 innings of 1.59 ERA ball and picked up four saves. His 21.1% strikeout rate was half that of his dominant 2021 form, but it was still an encouraging note on which to end the season.

Barnes might eventually get a fresh chance to carve out some save opportunities in Miami, though Dylan Floro is the current projected frontrunner for that gig. Floro worked to a 3.02 ERA across 53 2/3 innings with the Marlins in 2022, and he has successfully converted 25 save attempts over the last two years. Barnes tallied only eight saves in 2022 and finished with a 4.31 ERA in 39 2/3 frames. He’ll add quite a bit more bat-missing potential to a team that ranked 13th among MLB clubs with a 24% strikeout rate from its relief corps in 2022, though the downside is obvious.

Bleier, meanwhile, can fill the Sox’s need for left-handed bullpen help, even as he enters his age-36 season. The veteran southpaw has registered a 3.09 ERA in 125 1/3 innings since the beginning of 2020, and he’s held left-handed batters to a .225/.260/.313 slash line since he first reached the major leagues with the Yankees in 2016. Boston traded lefty Josh Taylor to the Royals in exchange for Adalberto Mondesi, sent veteran Jake Diekman (signed through 2023) to the White Sox at last year’s trade deadline and lost Darwinzon Hernandez to the Orioles via waivers earlier this offseason — all of which had thinned out the team’s left-handed depth in the ’pen.

They’ll get some quality left-handed innings out of Bleier, although despite his strong track record there are some red flags of note. The soft-tossing southpaw has never missed many bats, but last year’s 14.4% strikeout rate was his lowest since 2019. Bleier has, in the past, offset his lack of whiffs with enormous ground-ball rates. However, while last year’s 52.5% mark was strong relative to the league-average, it was nowhere close to the 63.5% career mark he carried into the 2022 season. Bleier has also regularly avoided hard contact, but last year’s 89.6 mph exit velocity and 40.8% hard-hit rate were both his worst showings since the aforementioned 2016 debut.

Barnes will make $7.5MM in 2023 and is due at least a $2.25MM buyout on a 2024 club option valued at $8MM. Bleier is due $3.25MM for the upcoming season and has a $3.75MM club option with a $250K buyout for next year. Barnes is guaranteed $9.75MM from here on out while Bleier will make at least $3.75MM. The Sox are covering the bulk of that $6MM gap with the $5.5MM+ cash consideration.

The Sox will save a minuscule amount of money and bring in a middle reliever with a solid overall track record and some particularly encouraging numbers against fellow lefties — even if Bleier comes with some potential areas of concern. That he can be controlled through 2024 via that affordable $3.75MM option is icing on the cake.

As for the Marlins, they’ll add more late-inning upside to their bullpen with this swap at almost no additional cost. Fans may bristle at shipping out the reliever with better surface-level numbers for what amounts to a Barnes reclamation project, but the Fish are willing to gamble on the younger, harder-throwing Barnes in hopes of unlocking a high-leverage reliever who can be controlled affordably through the 2024 season via that $8MM option. And, if Barnes is indeed able to round back into form, he’ll give Miami an interesting arm to put on the market this summer if they’re decisively out of postseason contention.

Ken Rosenthal of the Athletic first reported the Marlins were acquiring Barnes. Craig Mish of SportsGrid reported that Boston was acquiring Bleier in return. Jordan McPherson of the Herald was first to relay that Miami was receiving cash considerations, which Mish pegged in the $5MM range. Chris Coitllo of MassLive was first to report the cash involved was a little above $5.5MM.

Red Sox Designate Franklin German For Assignment

By | at

The Red Sox have officially announced their trade that sends right-hander Matt Barnes to the Marlins and sees lefty Richard Bleier come to Boston. To make room on the roster for Bleier, right-hander Franklin German was designated for assignment. Barnes was already off the roster since he was designated for assignment last week.

German, 25, was a Yankee farmhand that came to the Sox in the Adam Ottavino trade in 2021. He had primarily been a starter in the minors but he was used exclusively in relief in 2022. The move seemed to suit him well, as he posted a 2.72 ERA over 49 2/3 innings between Double-A and Triple-A. His 9.6% walk rate was a tad high but he paired that with a 32.5% strikeout rate. That showing was impressive enough to get him to the majors, though he was lit up for eight earned runs in his first four innings.

The Red Sox will now have a week to trade German or pass him through waivers. Though his first taste of the majors didn’t go well in terms of results, he did average 97.7 mph on his fastball. He could intrigue other clubs with his youth, excellent performance in the minors last year and full slate of options. He has just a few days of MLB service time thus far and can be affordably retained for the foreseeable future.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top